Information was received from a healthcare professional (hcp) and a manufacturer representative (rep) regarding a patient who was implanted with a neurostimulator for gastric stimulation.It was reported that the hcp had the device in the sterile field, tested it, but didn¿t like it so they took it off the field and brought another one in, which was implanted.The hcp didn¿t note what was wrong with it or why they didn¿t like it.On (b)(6) 2018, it was reported that the hcp tested it and it didn¿t meet their specifications.It was noted that the patient had recovered, without sequelae.No further complications were reported or anticipated.
|
The returned device was subjected to a series of standard tests that include but is not limited to visual inspection, output and telemetry testing, and functional testing.The returned device passed all testing in the laboratory and no anomalies were identified.If information is provided in the future, a supplemental report will be issued.
|